PAH Antibodies

Santa Cruz Biotechnology delivers a wide array of PAH monoclonal antibodies for studying phenylalanine hydroxylase (PAH) protein. PAH monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phenylalanine hydroxylase is a critical enzyme involved in the metabolism of the amino acid phenylalanine, converting it into tyrosine. This process is essential for the synthesis of neurotransmitters and other important biomolecules. Deficiencies in PAH can lead to phenylketonuria (PKU), a genetic disorder that can result in severe neurological consequences if not managed properly. Understanding the function and regulation of PAH is vital for developing therapeutic strategies for PKU and related metabolic disorders. Research utilizing PAH monoclonal antibodies enables investigation of PAH expression patterns and interactions within cellular pathways. Exploring PAH's role in amino acid metabolism can reveal new insights into metabolic disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for PAH support researchers worldwide in advancing scientific understanding of metabolic disorders and potential therapeutic approaches.